Literature DB >> 11997513

Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol.

Kamal D Mehta1, Anna Radominska-Pandya, Gurpreet S Kapoor, Bhuvanesh Dave, Brett A Atkins.   

Abstract

Induction of low-density lipoprotein (LDL) receptor transcription in response to depletion of cellular sterols in animal cells is well established. The intracellular signal or signals involved in regulating this process, however, remain unknown. Using a specific inhibitor of protein kinase C (PKC), calphostin C, we show the requirement of this kinase in the induction process in human hepatoma HepG2 cells. Overexpression of PKC epsilon, but not PKC alpha, -gamma, -delta, or -zeta was found to dramatically induce (approximately 18-fold) LDL receptor promoter activity. Interestingly, PKC epsilon-mediated induction was found to be sterol resistant. To further establish that PKC epsilon is involved in the sterol regulation of LDL receptor gene transcription, endogenous PKC epsilon was specifically inhibited by transfection with antisense PKC epsilon phosphorothionate oligonucleotides. Antisense treatment decreased endogenous PKC epsilon protein levels and completely blocked induction of LDL receptor transcription following sterol depletion. PKC epsilon-induced LDL receptor transcription is independent of the extracellular signal-regulated kinase 1 and 2 (p42/44(MAPK)) cascade, because the MEK-1/2 inhibitor, PD98059 did not inhibit, even though it blocked p42/44(MAPK) activation. Finally, photoaffinity labeling studies showed an isoform-specific interaction between PKC epsilon and sterols, suggesting that sterols may directly modulate its function by hampering binding of activators. This was confirmed by PKC activity assays. Altogether, these results define a novel signaling pathway leading to induction of LDL receptor transcription following sterol depletion, and a model is proposed to account for a new function for PKC epsilon as part of a sterol-sensitive signal transduction pathway in hepatic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997513      PMCID: PMC133812          DOI: 10.1128/MCB.22.11.3783-3793.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Identification of essential nucleotides of the FP1 element responsible for enhancement of low density lipoprotein receptor gene transcription.

Authors:  P Dhawan; R Chang; K D Mehta
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells.

Authors:  O Traub; B P Monia; N M Dean; B C Berk
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

3.  Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade.

Authors:  J Kotzka; D Müller-Wieland; G Roth; L Kremer; M Munck; S Schürmann; B Knebel; W Krone
Journal:  J Lipid Res       Date:  2000-01       Impact factor: 5.922

4.  Critical role of p42/44(MAPK) activation in anisomycin and hepatocyte growth factor-induced LDL receptor expression: activation of Raf-1/Mek-1/p42/44(MAPK) cascade alone is sufficient to induce LDL receptor expression.

Authors:  P Dhawan; A Bell; A Kumar; C Golden; K D Mehta
Journal:  J Lipid Res       Date:  1999-10       Impact factor: 5.922

5.  CBP associates with the p42/p44 MAPK enzymes and is phosphorylated following NGF treatment.

Authors:  Y Z Liu; N S Thomas; D S Latchman
Journal:  Neuroreport       Date:  1999-04-26       Impact factor: 1.837

6.  Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter.

Authors:  J Liu; T E Ahlborn; M R Briggs; F B Kraemer
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

7.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation.

Authors:  A Kumar; T C Chambers; B A Cloud-Heflin; K D Mehta
Journal:  J Lipid Res       Date:  1997-11       Impact factor: 5.922

9.  Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK).

Authors:  T Furuchi; R G Anderson
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

10.  The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation.

Authors:  P Garcia-Paramio; Y Cabrerizo; F Bornancin; P J Parker
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

View more
  8 in total

1.  Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.

Authors:  Abhik Sen; Daniel L Alkon; Thomas J Nelson
Journal:  J Biol Chem       Date:  2012-03-17       Impact factor: 5.157

2.  MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.

Authors:  Hong Yan; Yan-ling Ma; Yu-zhou Gui; Shu-mei Wang; Xin-bo Wang; Fei Gao; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2014-07-21       Impact factor: 6.150

3.  PKCε contributes to chronic ethanol-induced steatosis in mice but not inflammation and necrosis.

Authors:  J Phillip Kaiser; Luping Guo; Juliane I Beier; Jun Zhang; Aruni Bhatnagar; Gavin E Arteel
Journal:  Alcohol Clin Exp Res       Date:  2014-01-31       Impact factor: 3.455

Review 4.  Role of mitogen-activated protein kinases and protein kinase C in regulating low-density lipoprotein receptor expression.

Authors:  Kamal D Mehta
Journal:  Gene Expr       Date:  2002

5.  Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.

Authors:  Noelle B Vargas; Brandy Y Brewer; Terry B Rogers; Gerald M Wilson
Journal:  J Lipid Res       Date:  2008-10-20       Impact factor: 5.922

Review 6.  Protein kinase C and cardiac dysfunction: a review.

Authors:  Raphael M Singh; Emanuel Cummings; Constantinos Pantos; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

7.  Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort.

Authors:  Farsad Afshinnia; Thekkelnaycke M Rajendiran; Alla Karnovsky; Tanu Soni; Xue Wang; Dawei Xie; Wei Yang; Tariq Shafi; Matthew R Weir; Jiang He; Carolyn S Brecklin; Eugene P Rhee; Jeffrey R Schelling; Akinlolu Ojo; Harold Feldman; George Michailidis; Subramaniam Pennathur
Journal:  Kidney Int Rep       Date:  2016-08-18

Review 8.  Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis.

Authors:  Chih-Feng Lien; Sy-Jou Chen; Min-Chien Tsai; Chin-Sheng Lin
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.